FDA Regulatory-Rulemaking from Real-World Data from Registri

Food and Drug Administration draft guidance outlining recommendations for using real-world data from registries to support regulatory decision-making. Pharmaceutical manufacturers and other life-sciences industry stakeholders should review guidance & submit comments by February 28, 2022

Related Keywords

, Product Development To Support Labeling , Drug Administration , Real World Data , Assessing Registries , Support Regulatory Decision Making , Biological Products Guidance , Draft Guidance , Century Cures Act , Cures Act , Federal Food , Cosmetic Act , Regulatory Decision , Patient Reported Outcome Measures , Medical Product Development , Support Labeling , Linking Registries , Legal , Government , Regulation , Fda , Urating Data In Registries , Pharmaceutical Manufacturers , Ive Sciences Industry ,